IHL revenues soar following increased sales of Gameday mouthguards
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Developer and distributor of mouthguards and teeth whitening products, Impression Healthcare (ASX:IHL) recently provided a promising operational update which resulted in a substantial share price rerating.
It should be noted that share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.
As a backdrop, the company’s key products are Gameday Mouthguards, Instant Teeth Whitening (ITW) and Denti, all of which are successfully providing consumers with a more affordable option than traditional dental products.
With sales increasing more than 370% on a year-on-year basis in March, and quarterly revenue for the three months to March 31, 2017 exceeding full-year revenues for calendar year 2016, it wasn’t surprising to see the company’s share price spike more than 20%.
However, there could be more upside to come given that the company is only just starting to gain traction from extensive media campaigns which feature high profile ambassadors from popular sporting codes such as AFL, Rugby League, Basketball and Hockey.
The company has been preparing for a significant increase in demand for products having expanded its facilities, processes and laboratory inventories to enable the efficient delivery of 50,000 quality custom fit mouthguards per year.
Gameday aims to disrupt the mouthguard market and has developed a business plan whereby customers are able to take an impression of their teeth at home using the Gameday home impression kit, posting the impression back to Gameday and receiving a custom fit mouthguards in a short turnaround period.
Valuable partnerships with sporting bodies to underpin robust growth in 2017
Via its wholly-owned Gameday International subsidiary, IHL has entered into a number of partnership agreements with sports bodies at state and national level. This has taken its total marketing reach to more than 1 million members and participants of grassroots sporting associations.
These partnerships were established ahead of the commencement of the 2017 sports season, providing the group with direct marketing access to its target customer base.
Given that the company’s addressable market was much smaller in 2016 the traction gained from agreements forged with numerous sporting bodies in the last 12 months will reflect in the company’s sales growth figures in 2017/18.
Consequently, the substantial increases in revenues and customers illustrated in the following charts is likely to be surpassed in the coming 12 months.
IHL now a multi-product company
In March, the company made the transition from a single product company as it launched the Denti and ITW brands, facilitating expansion into the teeth whitening industry.
ITW is positioned as a mainstream, at home, teeth whitening product, providing consumers with a cost-effective, custom fit, at-home teeth whitening solution at a competitive price.
Denti is positioned as a premium teeth whitening product and includes a range of teeth whitening and beauty products. It will be marketed as a high quality premium brand to appeal to the discerning customer seeking a luxury product.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
